Jack Chovanec

530 total citations
7 papers, 235 citations indexed

About

Jack Chovanec is a scholar working on Immunology, Rheumatology and Cell Biology. According to data from OpenAlex, Jack Chovanec has authored 7 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Rheumatology and 2 papers in Cell Biology. Recurrent topics in Jack Chovanec's work include Mast cells and histamine (3 papers), Urticaria and Related Conditions (3 papers) and Food Allergy and Anaphylaxis Research (2 papers). Jack Chovanec is often cited by papers focused on Mast cells and histamine (3 papers), Urticaria and Related Conditions (3 papers) and Food Allergy and Anaphylaxis Research (2 papers). Jack Chovanec collaborates with scholars based in United States, Italy and Canada. Jack Chovanec's co-authors include Jonathan J. Lyons, Dean D. Metcalfe, Melody C. Carter, Ji-Won Kim, Lawrence B. Schwartz, Joshua D. Milner, Julij Šelb, Hirsh D. Komarow, Michael P. O’Connell and Roberta Zanotti and has published in prestigious journals such as The Journal of Immunology, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Jack Chovanec

7 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack Chovanec United States 5 167 138 71 52 47 7 235
Brett V. Kettelhut United States 7 270 1.6× 121 0.9× 159 2.2× 44 0.8× 36 0.8× 9 297
Thomas DiMaggio United States 5 89 0.5× 49 0.4× 19 0.3× 36 0.7× 9 0.2× 9 134
Yulia Dorofeeva Austria 6 52 0.3× 121 0.9× 24 0.3× 66 1.3× 7 0.1× 8 185
Björn van Anrooij Netherlands 5 144 0.9× 132 1.0× 72 1.0× 28 0.5× 19 0.4× 6 188
Nissera Bajrović Slovenia 11 73 0.4× 358 2.6× 52 0.7× 86 1.7× 101 2.1× 17 414
C. Mailhol France 7 68 0.4× 132 1.0× 54 0.8× 36 0.7× 22 0.5× 25 234
Sarah De Schryver Canada 4 43 0.3× 142 1.0× 8 0.1× 41 0.8× 24 0.5× 11 177
Howard Chu South Korea 10 47 0.3× 112 0.8× 21 0.3× 57 1.1× 4 0.1× 22 293
Ikuko Ogahara Japan 5 187 1.1× 20 0.1× 10 0.1× 59 1.1× 5 0.1× 5 297
Marlene Seegräber Germany 7 34 0.2× 140 1.0× 55 0.8× 74 1.4× 2 0.0× 14 257

Countries citing papers authored by Jack Chovanec

Since Specialization
Citations

This map shows the geographic impact of Jack Chovanec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Chovanec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Chovanec more than expected).

Fields of papers citing papers by Jack Chovanec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Chovanec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Chovanec. The network helps show where Jack Chovanec may publish in the future.

Co-authorship network of co-authors of Jack Chovanec

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Chovanec. A scholar is included among the top collaborators of Jack Chovanec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Chovanec. Jack Chovanec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Vázquez, Maribel, Jack Chovanec, Ji‐Won Kim, et al.. (2022). Hereditary alpha-tryptasemia modifies clinical phenotypes among individuals with congenital hypermobility disorders. Human Genetics and Genomics Advances. 3(2). 100094–100094. 7 indexed citations
2.
Mateja, Allyson, Jack Chovanec, Ji-Won Kim, et al.. (2021). Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis. Journal of Allergy and Clinical Immunology. 149(3). 1010–1017.e10. 47 indexed citations
3.
Kernien, John F., et al.. (2020). Neutrophils From Patients With Invasive Candidiasis Are Inhibited by Candida albicans Biofilms. Frontiers in Immunology. 11. 587956–587956. 14 indexed citations
4.
Lyons, Jonathan J., Jack Chovanec, Michael P. O’Connell, et al.. (2020). Heritable risk for severe anaphylaxis associated with increased α-tryptase–encoding germline copy number at TPSAB1. Journal of Allergy and Clinical Immunology. 147(2). 622–632. 144 indexed citations
5.
Lyons, Jonathan J., Stephanie C. Stotz, Jack Chovanec, et al.. (2017). A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number. Genetics in Medicine. 20(5). 503–512. 21 indexed citations
6.
Lyons, Jonathan J., Jack Chovanec, Quang Le, et al.. (2017). TPSAB1 Genotype and Effects of Pro-Tryptases on Human Mast Cell-Associated Disorders. Journal of Allergy and Clinical Immunology. 139(2). AB376–AB376. 1 indexed citations
7.
Chovanec, Jack, Yihui Liu, Yuzhi Yin, et al.. (2017). Correlation of alpha- and beta-specific tryptase gene expression with TPSAB1 and TPSB2 genotypes in humans. The Journal of Immunology. 198(Supplement_1). 59.13–59.13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026